Company intelligence / Profile preview

Ably Medical

Ownership: Private
Development stage: Other

Overview

Ably Medical has developed LYNG—a no-touch, real-time patient monitoring solution that automates the collection of vital signs such as heart rate, respiration, movement, temperature, blood pressure and more. The technology aims to reduce nurse workload by automating routine measurements and documentation. The company’s solutions are being piloted with hospitals internationally. Regulatory milestones include an upcoming CE-marked commercial launch with Class I medical device certification expected soon; pursuit of higher-risk Class IIb certification will follow in 2025.

Therapeutic areas: Other
Modalities: DeviceNon-pharmacological therapy
Industry: Physiological Monitoring

Partnerships

Collaborations with four Norwegian hospitals during development phaseContracts/pilots with Toronto-based institutionsPartners in Germany and Singapore for pilots/trials

Beyond the preview

Go deeper on Ably Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ably Medical.

Explore the full profile